Selective killing of transformed cells by cyclin/cyclin-dependent kinase 2 antagonists

被引:289
作者
Chen, YNP
Sharma, SK
Ramsey, TM
Jiang, L
Martin, MS
Baker, K
Adams, PD
Bair, KW
Kaelin, WG
机构
[1] Dana Farber Canc Inst, Howard Hughes Med Inst, Boston, MA 02115 USA
[2] Nova Pharmaceut Corp, Novartis Inst Biomed Res, Summit, NJ 07901 USA
[3] Harvard Univ, Sch Med, Boston, MA 02115 USA
关键词
D O I
10.1073/pnas.96.8.4325
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Recent studies identified a short peptide motif that serves as a docking site for cyclin/cyclin-dependent kinase (cdk) 2 complexes. Peptides containing this motif block the phosphorylation of substrates by cyclin A/cdk2 or cyclin E/cdk2. Here we report that cell membrane-permeable forms of such peptides preferentially induced transformed cells to undergo apoptosis relative to nontransformed cells. Deregulation of E2F family transcription factors is a common event during transformation and was sufficient to sensitize cells to the cyclin/cdk2 inhibitory peptides, These results suggest that deregulation of E2F and inhibition of cdk2 are synthetically lethal and provide a rationale for the development of cdk2 antagonists as antineoplastic agents.
引用
收藏
页码:4325 / 4329
页数:5
相关论文
共 29 条
  • [1] Adams PD, 1996, MOL CELL BIOL, V16, P6623
  • [2] NORMAL KERATINIZATION IN A SPONTANEOUSLY IMMORTALIZED ANEUPLOID HUMAN KERATINOCYTE CELL-LINE
    BOUKAMP, P
    PETRUSSEVSKA, RT
    BREITKREUTZ, D
    HORNUNG, J
    MARKHAM, A
    FUSENIG, NE
    [J]. JOURNAL OF CELL BIOLOGY, 1988, 106 (03) : 761 - 771
  • [3] Chen JJ, 1996, MOL CELL BIOL, V16, P4673
  • [4] DIFFERENTIAL REGULATION OF E2F TRANSACTIVATION BY CYCLIN CDK2 COMPLEXES
    DYNLACHT, BD
    FLORES, O
    LEES, JA
    HARLOW, E
    [J]. GENES & DEVELOPMENT, 1994, 8 (15) : 1772 - 1786
  • [5] Inhibition of pRb phosphorylation and cell-cycle progression by a 20-residue peptide derived from p16(CDKN2/INK4A)
    Fahraeus, R
    Paramio, JM
    Ball, KL
    Lain, S
    Lane, DP
    [J]. CURRENT BIOLOGY, 1996, 6 (01) : 84 - 91
  • [6] TAT-MEDIATED DELIVERY OF HETEROLOGOUS PROTEINS INTO CELLS
    FAWELL, S
    SEERY, J
    DAIKH, Y
    MOORE, C
    CHEN, LL
    PEPINSKY, B
    BARSOUM, J
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (02) : 664 - 668
  • [7] Overexpression of E2F-1 in glioma triggers apoptosis and suppresses tumor growth in vitro and in vivo
    Fueyo, J
    Gomez-Manzano, C
    Yung, WKA
    Liu, TJ
    Alemany, R
    McDonnell, TJ
    Shi, X
    Rao, JS
    Levin, VA
    Kyritsis, AP
    [J]. NATURE MEDICINE, 1998, 4 (06) : 685 - 690
  • [8] MULTIPLE DNA ELEMENTS ARE REQUIRED FOR THE GROWTH-REGULATION OF THE MOUSE E2F1 PROMOTER
    HSIAO, KM
    MCMAHON, SL
    FARNHAM, PJ
    [J]. GENES & DEVELOPMENT, 1994, 8 (13) : 1526 - 1537
  • [9] E2F1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction
    Hsieh, JK
    Fredersdorf, S
    Kouzarides, T
    Martin, K
    Lu, X
    [J]. GENES & DEVELOPMENT, 1997, 11 (14) : 1840 - 1852
  • [10] AUTOREGULATORY CONTROL OF E2F1 EXPRESSION IN RESPONSE TO POSITIVE AND NEGATIVE REGULATORS OF CELL-CYCLE PROGRESSION
    JOHNSON, DG
    OHTANI, K
    NEVINS, JR
    [J]. GENES & DEVELOPMENT, 1994, 8 (13) : 1514 - 1525